BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27094969)

  • 1. PSA testing and early management of test-detected prostate cancer--consensus at last.
    Lawrentschuk N
    BJU Int; 2016 Apr; 117 Suppl 4():5-6. PubMed ID: 27094969
    [No Abstract]   [Full Text] [Related]  

  • 2. The Melbourne Consensus Statement on the early detection of prostate cancer.
    Murphy DG; Ahlering T; Catalona WJ; Crowe H; Crowe J; Clarke N; Cooperberg M; Gillatt D; Gleave M; Loeb S; Roobol M; Sartor O; Pickles T; Wootten A; Walsh PC; Costello AJ
    BJU Int; 2014 Feb; 113(2):186-8. PubMed ID: 24206066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Implementation of guidelines for PSA testing in general practice].
    Jodal HC; Reyes YD; Roksund G; Bretthauer M
    Tidsskr Nor Laegeforen; 2014 Nov; 134(21):2032-4. PubMed ID: 25387926
    [No Abstract]   [Full Text] [Related]  

  • 5. Falling through the cracks: New Zealand prostate cancer survivors' experiences and views regarding PSA testing.
    Patel A; MacLeod R; Masters J; Keogh J
    N Z Med J; 2014 Aug; 127(1400):106-9. PubMed ID: 25145373
    [No Abstract]   [Full Text] [Related]  

  • 6. [Large part of Swedish men PSA tested for early prostatic cancer. Few aware of the disadvantages of the test].
    Bratt O; Grenabo L
    Lakartidningen; 2010 Feb 17-23; 107(7):432-5. PubMed ID: 20384075
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate cancer: measuring PSA.
    Pezaro C; Woo HH; Davis ID
    Intern Med J; 2014 May; 44(5):433-40. PubMed ID: 24816306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSA screening: the USPSTF got it wrong.
    Scherger JE
    J Fam Pract; 2013 Nov; 62(11):616, 618. PubMed ID: 24288701
    [No Abstract]   [Full Text] [Related]  

  • 9. An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.
    Crawford ED; Rosenberg MT; Partin AW; Cooperberg MR; Maccini M; Loeb S; Pettaway CA; Shore ND; Arangua P; Hoenemeyer J; Leveridge M; Leapman M; Pinto P; Thompson IM; Carroll P; Eastham J; Gomella L; Klein EA
    Urology; 2016 Oct; 96():116-120. PubMed ID: 27450937
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for prostate cancer: time to put all the data on the table.
    Haines IE; Ablin RJ; Miklos GL
    BMJ; 2016 May; 353():i2574. PubMed ID: 27226459
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate-specific antigen-based prostate cancer screening: Past and future.
    Alberts AR; Schoots IG; Roobol MJ
    Int J Urol; 2015 Jun; 22(6):524-32. PubMed ID: 25847604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate specific antigen best practice statement: 2009 update.
    Greene KL; Albertsen PC; Babaian RJ; Carter HB; Gann PH; Han M; Kuban DA; Sartor AO; Stanford JL; Zietman A; Carroll P
    J Urol; 2009 Nov; 182(5):2232-41. PubMed ID: 19781717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revised status of PSA testing in the early detection and treatment of prostate cancer.
    Lamb DS; Delahunt B; Nacey JN
    N Z Med J; 2011 Nov; 124(1345):13-5. PubMed ID: 22072161
    [No Abstract]   [Full Text] [Related]  

  • 14. Liaise with pathologists to refine understanding of the prostate-specific antigen test.
    Sikaris KA; Ross BA; Khong TY
    Med J Aust; 2013 Nov; 199(10):656, 658. PubMed ID: 24237087
    [No Abstract]   [Full Text] [Related]  

  • 15. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
    Prasad SM; Drazer MW; Huo D; Hu JC; Eggener SE
    JAMA; 2012 Apr; 307(16):1692-4. PubMed ID: 22535850
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer.
    Barry MJ
    N Engl J Med; 2001 May; 344(18):1373-7. PubMed ID: 11333995
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: Prostate cancer screening: perhaps a little patience is the answer.
    Jarrett TW
    Can J Urol; 2012 Oct; 19(5):6409. PubMed ID: 23040616
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for prostate cancer.
    Croswell J; Shin YR
    Am Fam Physician; 2013 Feb; 87(4):283-4. PubMed ID: 23418805
    [No Abstract]   [Full Text] [Related]  

  • 19. Perspective on...the new PSA screening recommendations.
    Marsland T; Arena F; Yeilding A; Glodé M; Ellis L; Yu J; Henderson C; Wagman L; Piver S; Minsky B; Rosen S; Poplack D; Potters L; Crawford D; Hoskins W
    Oncology (Williston Park); 2011 Nov; 25(12):1183, 1187-8, 1190. PubMed ID: 22229211
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate cancer: Prudent practice optimizes screening outcomes.
    Auvinen A
    Nat Rev Urol; 2016 Jul; 13(7):376-7. PubMed ID: 27215425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.